• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Consumer Discretionary

Walgreens-Rite Aid Deal Depends on Selling Stores

Walgreens' ability to divest itself of assets is crucial to it obtaining regulatory approval in its bid to acquire Rite Aide.
By CARLETON ENGLISH Apr 11, 2016 | 12:45 PM EDT
Stocks quotes in this article: WBA, RAD, SPLS, ODP, AGN

Announced mergers do not always become completed mergers. Deals are often subject to regulatory approval, shareholder votes and changes in circumstances in the time between when a deal is announced and when it is expected to close. 

In this climate, who is to say that Action Alerts PLUS holding Walgreens Boots Alliance's (WBA) $17.2 billion (including debt) bid to take over Rite Aid (RAD) is immune from similar challenges?

This year has already seen mergers challenged due to a mix of regulatory concerns. Staples' (SPLS) $6.3 billion bid to acquire Office Depot (ODP) has been challenged on antitrust grounds, though there is evidence that the deal could go through. Meanwhile, Pfizer's (PFE) plans to acquire Action Alerts PLUS holding Allergan (AGN) in a $150 billion deal were shot down last week, following new regulations from the U.S. Treasury Department to prevent corporate tax inversion deals.

"I now think that Rite Aid is being run down while this deal waits clearance," Jim Cramer told Real Money. "I think Walgreens' stock represents the worst possible scenario: no Rite Aid to fix up and no chance for the company to expand away from it."

Both Walgreens and Rite Aid reported first-quarter earnings last week and were roughly in line with analyst targets. However, an analyst team at Credit Suisse took a slightly more optimistic outlook on Walgreens and raised its price target to $95 from $92; meanwhile, it said Rite Aid's performance was "respectable." Credit Suisse has Outperform ratings on both companies.

With respect to Walgreens' plans to acquire Rite Aid, the Illinois-based company will have to divest itself of stores to avoid regulatory scrutiny. In a presentation released in November, Walgreens said its contract provides for divestments up to 1,000 stores, though it expects that the actual number will be less than 500. Either way, it's no easy task as Walgreens has to find "legitimate buyers" at "competitive pricing," which means no fire sales and no closing stores, said Jack Mohr, research director of Action Alerts PLUS.

Walgreens is currently the largest retail pharmacy in the U.S. and Europe, with 13,100 stores in over 11 countries. Its second competitor is CVS Health (CVS), with 9,600 stores in the U.S. and Brazil. Rite Aid comes in third, which means a merger would put even more distance between frontrunner Walgreens and CVS.

Mohr said that some of the concerns of price increases resulting from the merger can be dismissed as retail pharmacies have been absorbing prices instead of raising prices in light of reimbursement pressures. Despite their scale, retail pharmacy behemoths such as CVS and Walgreens have had difficulty renegotiating drug prices with third party pharmacy benefit managers.

Looking at the broader retail offerings in pharmacies, Mohr said that there is enough competition elsewhere from big box retailers to still compete on prices for other goods.

The focus of the Federal Trade Commission's investigation will be on how Walgreens divests itself from stores.

During an earnings call with analysts last week, Walgreens CEO Stefano Pessina said that the regulatory approval process is moving along in its expected timeline. During the question and answer portion of the call, Pessina acknowledged that the process had been "very long" and that Walgreens had provided "many, many documents."

"The process is developing in an absolute normal way and so we hope that, sooner or later, we will have an indication on where we are, but of course, we cannot put a day or even a month for this indication because it depends very much on how deeply the FTC wants to analyze all of the documents that we have given," Pessina said.

The reason for the enhanced sensitivity on Walgreens divestitures could be due in part to complications from Albertson's merger with Safeway two years ago, Mohr said. Under the terms of that transaction, Safeway had to divest itself of 168 stores. It ultimately sold 146 stores to Haggen, which filed for Chapter 11 protection a year later and closed 33 stores -- effectively negating some of the intended effect of the divestitures.

The terms of the merger agreement state that the deal has an Oct. 27, 2016, termination date, which is exactly one year after the deal was announced but the deal could be extended by three months.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from owning individual securities.

Credit Suisse provided investment banking services to RAD within the last twelve months.

TAGS: Investing | U.S. Equity | Consumer Discretionary

More from Consumer Discretionary

Boot Barn Gets a Quant Upgrade: Do the Charts Fit?

Bruce Kamich
Jan 19, 2021 1:53 PM EST

Here's our latest analysis and trading strategy for the shares.

Signet Jewelers May Retest the Breakout From Its Base Pattern

Bruce Kamich
Jan 15, 2021 8:09 AM EST

There is a risk of a pullback to the top of the base pattern or down to the $30 area.

Norwegian Cruise Lines Fights to Survive

Jonathan Heller
Jan 13, 2021 11:00 AM EST

The markets appear to be looking forward for the cruise industry.

Coca-Cola Could Turn Lower as the Bullish Fizz Is Escaping

Bruce Kamich
Jan 6, 2021 9:15 AM EST

Price momentum often weakens before a turn lower.

Planet Fitness Charts Suggest Its Shares Could Use Some Firming Up

Bruce Kamich
Jan 6, 2021 8:11 AM EST

The technical signals indicate that the stock of the fitness chain could head lower in the weeks ahead.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:09 AM EST GARY BERMAN

    Is Copper About to Turn to Rust?

    Below is a very long-term copper chart.  As you...
  • 08:02 AM EST GARY BERMAN

    Tuesday Morning Fibocall for for 1/19/2021

    SPX (Long-Term View) The 1/8/21 high @ 3826.69 i...
  • 09:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    When it's time to sell, will you act or freeze?
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login